• Thu, August 8, 2024

Matthew Biegler Maintained (TYRA) at Buy with Decreased Target to $25 on, Aug 8th, 2024

Matthew Biegler of Oppenheimer, Maintained "Tyra Biosciences, Inc." (TYRA) at Buy with Decreased Target from $28 to $25 on, Aug 8th, 2024.

Matthew has made no other calls on TYRA in the last 4 months.



There is 1 other peer that has a rating on TYRA. Out of the 1 peers that are also analyzing TYRA, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Mitchell Kapoor of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $23 on, Wednesday, July 3rd, 2024

Like: 👍